[Acid lysuride maleate in the prevention of migraine headache. Clinical experience].
Clinical experience of lysuride maleate acid in the treatment of 88 patients with occasional and 12 patients with chronic headache is reported. After 3-5 months observations the treatment was judged effective (excellent, good, satisfactory) in 72% of the cases and ineffective (poor, nil) in 28%. Side effects were few and short-lived, consisting mainly of slight nausea and asthenia. In 2 cases treatment was suspended as ineffective (in the patient's opinion).
D000293:Adolescent; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008090:Lisuride / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D013064:Speech Disorders / Q000139:chemically induced; D014202:Tremor / Q000139:chemically induced
D004873:Ergolines; D008090:Lisuride
Il lisuride maleato acido nella profilassi della cefalea emicranica. Esperienza clinica.